1.
|
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ACCOG-SCTN-BR0101, SCTN-BR0101, EU-20143, NCT00030758
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
4.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 and under
Sponsor: Other
Protocol IDs: CDR0000066400, MSGCC-9739, NCI-V98-1433, NCT00003398
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PDL-3-251, MSKCC-93131, NCI-V94-0469
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 16 to 50
Sponsor: Other
Protocol IDs: EORTC-30983, NCT00003643
|
|
8.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 12 to 50
Sponsor: Other
Protocol IDs: CHIMERIC-HM01, WSU-10-02-99-M01-FB, NCT00004255
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: E-1193, NCCTG-923252, SWOG-9332, E-10292, E1193
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AHOD0121, NCT00070187, AHOD0121
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 04/Q1907/94, NCT00234143
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 to 69
Sponsor: Other
Protocol IDs: JCOG0203, C000000033, NCT00147121
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000066016, P30CA016059, MCV-CCHR-9504-2X, DUMC-75951, NCI-G98-1388, NCT00003187
|
|
15.
|
Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: FCCC-94001, NCI-V94-0479
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9313, CLB-9394, E-S9313, NCCTG-933051, INT-0137
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000063311, EORTC-06931, NCT00002549
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: no greater than 60
Sponsor: NCI
Protocol IDs: NU-93B1, NCI-T93-0058D, T93-0058
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-26
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9342, CALGB-9342
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no greater than 65
Sponsor: NCI
Protocol IDs: FHCRC-772.01, NCI-H94-0370
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU19, EU-93027
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: POG-9331, CCG-9932, INT-0140
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CLB-9344, E-C9344, NCCTG-943051, SWOG-9410, INT-0148
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018
|
Mobile | Español
